Total words: 3821 | 2-word phrases: 1005 | 3-word phrases: 1102 | 4-word phrases: 1143
PAGE INFO
Title | Try to keep the title under 60 characters (70 characters) CNHIM - Centre National Hospitalier d’Information sur le Médicament |
Description | Try to keep the meta description between 50 - 160 characters (0 characters) |
Keywords | Meta keywords are not recommended anymore (0 characters) |
H1 | No H1 tag on the page (0 characters) |
ONE WORD PHRASES 571 Words
# |
Keyword |
H1 |
Title |
Des |
Volume |
Position |
Suggest |
Frequency |
Density |
1 | de | | | | | | | 53 | 9.28% |
2 | la | | | | | | | 35 | 6.13% |
3 | le | | | | | | | 34 | 5.95% |
4 | du | | | | | | | 30 | 5.25% |
5 | cnhim | | | | | | | 30 | 5.25% |
6 | et | | | | | | | 24 | 4.20% |
7 | en | | | | | | | 23 | 4.03% |
8 | des | | | | | | | 22 | 3.85% |
9 | 2023 | | | | | | | 20 | 3.50% |
10 | dossier | | | | | | | 18 | 3.15% |
TWO WORD PHRASES 1005 Words
# |
Keyword |
H1 |
Title |
Des |
Volume |
Position |
Suggest |
Frequency |
Density |
1 | du cnhim | | | | | | | 19 | 1.89% |
2 | dossier du | | | | | | | 15 | 1.49% |
3 | publié le | | | | | | | 11 | 1.09% |
4 | lire la | | | | | | | 10 | 1.00% |
5 | la suite | | | | | | | 9 | 0.90% |
6 | … lire | | | | | | | 9 | 0.90% |
7 | 2023 dossier | | | | | | | 8 | 0.80% |
8 | 2023 xliv | | | | | | | 8 | 0.80% |
9 | cnhim 2023 | | | | | | | 7 | 0.70% |
10 | prise en | | | | | | | 7 | 0.70% |
11 | suite publié | | | | | | | 6 | 0.60% |
12 | de la | | | | | | | 5 | 0.50% |
13 | février 2023 | | | | | | | 5 | 0.50% |
14 | et le | | | | | | | 5 | 0.50% |
15 | 20 février | | | | | | | 5 | 0.50% |
16 | thériaque info | | | | | | | 4 | 0.40% |
17 | en charge | | | | | | | 4 | 0.40% |
18 | 4 dossier | | | | | | | 4 | 0.40% |
19 | de sa | | | | | | | 4 | 0.40% |
20 | la prise | | | | | | | 4 | 0.40% |
THREE WORD PHRASES 1102 Words
# |
Keyword |
H1 |
Title |
Des |
Volume |
Position |
Suggest |
Frequency |
Density |
1 | dossier du cnhim | | | | | | | 14 | 1.27% |
2 | … lire la | | | | | | | 9 | 0.82% |
3 | lire la suite | | | | | | | 9 | 0.82% |
4 | 2023 dossier du | | | | | | | 7 | 0.64% |
5 | cnhim 2023 xliv | | | | | | | 7 | 0.64% |
6 | la suite publié | | | | | | | 6 | 0.54% |
7 | suite publié le | | | | | | | 6 | 0.54% |
8 | du cnhim 2023 | | | | | | | 6 | 0.54% |
9 | publié le 1 | | | | | | | 4 | 0.36% |
10 | la prise en | | | | | | | 4 | 0.36% |
11 | prise en charge | | | | | | | 4 | 0.36% |
12 | 4 dossier du | | | | | | | 4 | 0.36% |
13 | 25 août 2023 | | | | | | | 3 | 0.27% |
14 | février 2023 dossier | | | | | | | 3 | 0.27% |
15 | 2024 dossier du | | | | | | | 3 | 0.27% |
16 | 24 juillet 2023 | | | | | | | 3 | 0.27% |
17 | 202220 février 2023 | | | | | | | 3 | 0.27% |
18 | du cnhim 2022 | | | | | | | 3 | 0.27% |
19 | actualité du cnhim | | | | | | | 3 | 0.27% |
20 | – pharmacie clinique | | | | | | | 2 | 0.18% |
21 | 12 – pharmacie | | | | | | | 2 | 0.18% |
22 | xlv 12 – | | | | | | | 2 | 0.18% |
23 | 2024 xlv 12 | | | | | | | 2 | 0.18% |
24 | publié le 25 | | | | | | | 2 | 0.18% |
25 | février 2024 dossier | | | | | | | 2 | 0.18% |
26 | xliv 4 – | | | | | | | 2 | 0.18% |
27 | 2023 xliv 4 | | | | | | | 2 | 0.18% |
28 | pharmacie clinique en | | | | | | | 2 | 0.18% |
29 | du cnhim actualité | | | | | | | 2 | 0.18% |
30 | juillet 2023 dossier | | | | | | | 2 | 0.18% |
FOUR WORD PHRASES 1143 Words
# |
Keyword |
H1 |
Title |
Des |
Volume |
Position |
Suggest |
Frequency |
Density |
1 | … lire la suite | | | | | | | 8 | 0.70% |
2 | dossier du cnhim 2023 | | | | | | | 6 | 0.52% |
3 | lire la suite publié | | | | | | | 6 | 0.52% |
4 | la suite publié le | | | | | | | 6 | 0.52% |
5 | 2023 dossier du cnhim | | | | | | | 6 | 0.52% |
6 | du cnhim 2023 xliv | | | | | | | 6 | 0.52% |
7 | 4 dossier du cnhim | | | | | | | 4 | 0.35% |
8 | 2024 dossier du cnhim | | | | | | | 3 | 0.26% |
9 | février 2023 dossier du | | | | | | | 2 | 0.17% |
10 | le … lire la | | | | | | | 2 | 0.17% |
11 | et prise en charge | | | | | | | 2 | 0.17% |
12 | du cnhim 2022 xliii | | | | | | | 2 | 0.17% |
13 | dossier du cnhim 2022 | | | | | | | 2 | 0.17% |
14 | 202220 février 2023 dossier | | | | | | | 2 | 0.17% |
15 | effets risques et prise | | | | | | | 2 | 0.17% |
16 | pharmacie clinique en france | | | | | | | 2 | 0.17% |
17 | ptt chez l’adulteplace du | | | | | | | 2 | 0.17% |
18 | actualité du cnhim actualité | | | | | | | 2 | 0.17% |
19 | 2023 xliv 3 – | | | | | | | 2 | 0.17% |
20 | 2024 xlv 12 – | | | | | | | 2 | 0.17% |
21 | cnhim 2023 xliv 3 | | | | | | | 2 | 0.17% |
22 | cnhim dossier du cnhim | | | | | | | 2 | 0.17% |
23 | 24 juillet 2023 dossier | | | | | | | 2 | 0.17% |
24 | cnhim 2023 xliv 56 | | | | | | | 2 | 0.17% |
25 | – addictions aux substances | | | | | | | 2 | 0.17% |
26 | – pharmacie clinique en | | | | | | | 2 | 0.17% |
27 | 12 – pharmacie clinique | | | | | | | 2 | 0.17% |
28 | xlv 12 – pharmacie | | | | | | | 2 | 0.17% |
29 | février 2024 dossier du | | | | | | | 2 | 0.17% |
30 | risques et prise en | | | | | | | 2 | 0.17% |
31 | 2023 xliv 4 – | | | | | | | 2 | 0.17% |
32 | dans la prise en | | | | | | | 2 | 0.17% |
33 | juillet 2023 dossier du | | | | | | | 2 | 0.17% |
34 | suite publié le 1 | | | | | | | 2 | 0.17% |
35 | légale conditions générales de | | | | | | | 2 | 0.17% |
36 | sfpo et le cnhim | | | | | | | 2 | 0.17% |
37 | mention légale conditions générales | | | | | | | 2 | 0.17% |
38 | existe deux types de | | | | | | | 1 | 0.09% |
39 | du 1er janvier 2022 | | | | | | | 1 | 0.09% |
40 | 1er janvier 2022 oncotheriaque | | | | | | | 1 | 0.09% |
EXTERNAL LINKS
# |
URL |
Whois |
Check |
1 | https://sfpo.com/
| Whois | sfpo.com |
2 | http://www.oncotheriaque.org
| Whois | oncotheriaque.org |
3 | http://www.oncotheriaque.org
| Whois | oncotheriaque.org |
4 | http://x0w4i.mjt.lu/lnk/AUwAAER87j0AAcgy4RQAAKjhgUIAAAAAfFsAmxTwAA0wQABhze56v1sudLBgQx6w2M8arloz2gANJn0/1/teY-xU-G3r_xh0Kgjt4xaQ/aHR0cHM6Ly93d3cub25jb3RoZXJpYXF1ZS5vcmcvZXh0cmFuZXQvYWJvbm5lbWVudA
| Whois | mjt.lu |